Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.45% | -8.65% | -1.74% | 5.16% | 18.08% |
| Total Depreciation and Amortization | 3.03% | -0.64% | 0.65% | -3.24% | -2.45% |
| Total Amortization of Deferred Charges | -1.69% | 0.00% | 0.00% | 3.51% | 0.00% |
| Total Other Non-Cash Items | 10.17% | 6.76% | 2.77% | -2.49% | 17.64% |
| Change in Net Operating Assets | 116.05% | -121.00% | -47.06% | -283.10% | 77.83% |
| Cash from Operations | 77.92% | -81.26% | -24.35% | -47.27% | 62.00% |
| Capital Expenditure | -145.88% | 14.35% | -36.04% | 23.27% | -51.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -148.10% | 1,708.61% | -114.47% | 141.60% | -392.88% |
| Cash from Investing | -154.53% | 1,222.85% | -121.19% | 138.92% | -413.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 711.54% | -91.83% | 43.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 711.54% | -91.83% | 43.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.59% | 126.94% | -1,239.34% | 103.55% | -349.85% |
